Literature DB >> 2942429

Keratan sulfate proteoglycan during embryonic development of the chicken cornea.

J L Funderburgh, B Caterson, G W Conrad.   

Abstract

Antibodies to corneal keratan sulfate proteoglycan (KSPG) were used to characterize the pattern of KSPG accumulation during differentiation of neural crest cells in the stroma of embryonic chick cornea. Immunohistochemistry with monoclonal antibody I22 to keratan sulfate found this KSPG antigen localized inside stromal cells at stage 29 (Day 6), ca. 12 hr after migration into the primary stroma. A 2- to 3-day lag then occurred before appearance of extracellular keratan sulfate, first seen on Day 9 (Stage 35) in the posterior stroma. Keratan sulfate antigen accumulated in a posterior to anterior direction during subsequent development. Uniform staining of the stroma for keratan sulfate did not occur until after Day 16. Among several tissues, only corneal stroma contained an extracellular matrix which stained for keratan sulfate, though intracellular staining of some cartilage cells was observed. Accumulation of KSPG antigens in developing cornea was measured in unfractionated guanidine extracts with a quantitative ELISA using three different antibodies against KSPG. Increases were first detected after Day 9 using monoclonal I22, and somewhat later with the other two antibodies. Assays with all three antibodies detected a sustained, exponential increase of KSPG throughout the 5 days prior to hatching. Keratan sulfate continued to accumulate after hatching, but an antibody with specificity to KSPG core protein, detected no relative increase in antigen after hatching. This suggests a modulation of KSPG primary structure late in development and after hatching. Overt differentiation of individual neural crest cells thus appears to begin ca. 12 hr after their arrival in the primary stroma; a lag of 2-3 days precedes active secretion of KSPG.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2942429     DOI: 10.1016/0012-1606(86)90130-2

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  20 in total

1.  The engineering of organized human corneal tissue through the spatial guidance of corneal stromal stem cells.

Authors:  Jian Wu; Yiqin Du; Simon C Watkins; James L Funderburgh; William R Wagner
Journal:  Biomaterials       Date:  2011-11-10       Impact factor: 12.479

Review 2.  Importance of the stem cell microenvironment for ophthalmological cell-based therapy.

Authors:  Peng-Xia Wan; Bo-Wen Wang; Zhi-Chong Wang
Journal:  World J Stem Cells       Date:  2015-03-26       Impact factor: 5.326

Review 3.  Regulation of corneal stroma extracellular matrix assembly.

Authors:  Shoujun Chen; Michael J Mienaltowski; David E Birk
Journal:  Exp Eye Res       Date:  2015-04       Impact factor: 3.467

Review 4.  The molecular basis of corneal transparency.

Authors:  John R Hassell; David E Birk
Journal:  Exp Eye Res       Date:  2010-07-03       Impact factor: 3.467

5.  Corneal stromal stem cells versus corneal fibroblasts in generating structurally appropriate corneal stromal tissue.

Authors:  Jian Wu; Yiqin Du; Mary M Mann; James L Funderburgh; William R Wagner
Journal:  Exp Eye Res       Date:  2014-01-15       Impact factor: 3.467

6.  Structural remodeling of proteoglycans upon retinoic acid-induced differentiation of NCCIT cells.

Authors:  Leyla Gasimli; Hope E Stansfield; Alison V Nairn; Haiying Liu; Janet L Paluh; Bo Yang; Jonathan S Dordick; Kelley W Moremen; Robert J Linhardt
Journal:  Glycoconj J       Date:  2012-10-02       Impact factor: 2.916

7.  Developmental changes in the type I procollagen processing pathway in chick-embryo cornea.

Authors:  S J Mellor; G L Atkins; D J Hulmes
Journal:  Biochem J       Date:  1991-06-15       Impact factor: 3.857

8.  Wounded embryonic corneas exhibit nonfibrotic regeneration and complete innervation.

Authors:  James W Spurlin; Peter Y Lwigale
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-09-24       Impact factor: 4.799

9.  Proteomic analysis of potential keratan sulfate, chondroitin sulfate A, and hyaluronic acid molecular interactions.

Authors:  Abigail H Conrad; Yuntao Zhang; Elena S Tasheva; Gary W Conrad
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-04-07       Impact factor: 4.799

10.  Macular corneal dystrophy: mutational spectrum in German patients, novel mutations and therapeutic options.

Authors:  Claudia Gruenauer-Kloevekorn; Saskia Braeutigam; Wolfram Heinritz; Ursula G Froster; Gernot I W Duncker
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-05-24       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.